X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
animals (486) 486
humans (340) 340
index medicus (334) 334
phosphatidylglycerols - chemistry (322) 322
biochemistry & molecular biology (289) 289
phosphatidylglycerols - metabolism (276) 276
pharmacology & pharmacy (247) 247
phosphatidylglycerols - pharmacology (206) 206
lipids (202) 202
phosphatidylglycerol (187) 187
liposomes (186) 186
rats (160) 160
phospholipids (154) 154
male (143) 143
kinetics (137) 137
biophysics (136) 136
female (128) 128
mice (123) 123
membranes (122) 122
microbiology (122) 122
phosphatidylcholines - chemistry (122) 122
phosphatidylglycerols (117) 117
lipid bilayers - chemistry (113) 113
cell membrane - metabolism (111) 111
liposomes - chemistry (111) 111
analysis (110) 110
anti-bacterial agents - pharmacology (108) 108
phospholipids - metabolism (108) 108
amino acid sequence (106) 106
drug combinations (105) 105
peptides (93) 93
temperature (90) 90
cell membrane - drug effects (87) 87
molecular sequence data (87) 87
phosphatidylcholines - metabolism (84) 84
research (81) 81
research article (81) 81
phosphatidylglycerols - biosynthesis (77) 77
liposomes - metabolism (72) 72
microbial sensitivity tests (72) 72
binding (71) 71
hydrogen-ion concentration (70) 70
cell membrane - chemistry (67) 67
phospholipids - chemistry (67) 67
antimicrobial cationic peptides - pharmacology (65) 65
structure-activity relationship (64) 64
lipid bilayers - metabolism (63) 63
phosphatidylglycerols - therapeutic use (63) 63
chemistry, multidisciplinary (62) 62
proteins (62) 62
anti-bacterial agents - chemistry (61) 61
cell biology (61) 61
phosphatidylethanolamines - chemistry (61) 61
dose-response relationship, drug (60) 60
protein binding (59) 59
1,2-dipalmitoylphosphatidylcholine - chemistry (58) 58
circular dichroism (58) 58
phosphatidylcholines - pharmacology (58) 58
phosphatidylglycerols - administration & dosage (58) 58
escherichia-coli (56) 56
in vitro techniques (56) 56
protein structure, secondary (56) 56
cells, cultured (55) 55
surface active agents (54) 54
escherichia coli - drug effects (53) 53
time factors (53) 53
cholesterol (52) 52
rabbits (52) 52
cells (51) 51
amphotericin b - therapeutic use (50) 50
antimicrobial peptides (50) 50
pulmonary surfactants - pharmacology (50) 50
fluorescence (49) 49
phosphatidylcholine (49) 49
phosphatidylcholines - therapeutic use (49) 49
spectrometry, fluorescence (49) 49
article (48) 48
cell line (48) 48
lung - drug effects (48) 48
membrane (48) 48
phosphatidylglycerols - analysis (48) 48
phospholipids - pharmacology (48) 48
cattle (47) 47
phosphatidylcholines (47) 47
bacteria (46) 46
escherichia coli - metabolism (46) 46
in-vitro (46) 46
pulmonary surfactant (46) 46
amphotericin b - administration & dosage (45) 45
antimicrobial cationic peptides - chemistry (45) 45
dimyristoylphosphatidylcholine - chemistry (45) 45
infectious diseases (45) 45
peptides - chemistry (45) 45
physiological aspects (45) 45
calcium - pharmacology (44) 44
phosphatidylcholines - administration & dosage (44) 44
vesicles (44) 44
cardiolipins - metabolism (43) 43
membrane lipids - metabolism (43) 43
particle size (43) 43
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLOS ONE, ISSN 1932-6203, 10/2012, Volume 7, Issue 10, p. e47631
Background: Respiratory distress syndrome in preterm babies is caused by a pulmonary surfactant deficiency, but also by its inactivation due to various... 
PULMONARY SURFACTANT | PROTEIN-A | FILMS | INFLAMMATION | MULTIDISCIPLINARY SCIENCES | INFANTS | PREMATURE RABBITS | RESPIRATORY-DISTRESS-SYNDROME | IMMATURE NEWBORN RABBITS | EXOGENOUS SURFACTANT | NATURAL SURFACTANT | Phosphatidylglycerols - administration & dosage | Lung - pathology | Premature Birth - drug therapy | Pulmonary Surfactant-Associated Protein C - pharmacology | Phospholipids - administration & dosage | Premature Birth - mortality | Male | Pulmonary Surfactant-Associated Proteins - pharmacology | Biological Products - pharmacology | Lung - physiopathology | Phospholipids - pharmacology | Pulmonary Surfactants - pharmacology | Pulmonary Surfactant-Associated Proteins - administration & dosage | Pregnancy | 1,2-Dipalmitoylphosphatidylcholine - administration & dosage | Animals | Pulmonary Surfactant-Associated Protein B - pharmacology | Lung - drug effects | Phosphatidylglycerols - pharmacology | Female | Sheep | 1,2-Dipalmitoylphosphatidylcholine - pharmacology | Biological Products - administration & dosage | Pulmonary Surfactants - administration & dosage | Prevention | Usage | Respiratory distress syndrome | Surface active agents | Infants (Premature) | Physiological aspects | Research | Risk factors | Blood proteins | Compression | Films | Medical services | Inactivation | pH effects | Gestational age | Analogs | Newborn babies | Rodents | Alveoli | Respiratory therapy | Ventilators | Rabbits | Deactivation | Albumin | Bronchus | Histology | Serum albumin | Protein B | Survival | Babies | Lungs | Ventilation | In vivo methods and tests | Oxygenation
Journal Article
Journal Article
Nature, ISSN 0028-0836, 2014, Volume 510, Issue 7503, pp. 172 - 175
Previous studies have established that the folding, structure and function of membrane proteins are influenced by their lipid environments(1-7) and that lipids... 
MYCOBACTERIUM-TUBERCULOSIS | ATOM FORCE-FIELD | MOLECULAR-DYNAMICS | MULTIDISCIPLINARY SCIENCES | COMPLEXES | PURIFICATION | ION-CHANNEL | MOBILITY-MASS SPECTROMETRY | MODEL | MSCL | WATER | Apoproteins - chemistry | Cardiolipins - pharmacology | Protein Unfolding - drug effects | Protein Conformation - drug effects | Aquaporins - chemistry | Bacterial Proteins - chemistry | Substrate Specificity | Crystallography, X-Ray | Membrane Lipids - chemistry | Cation Transport Proteins - metabolism | Protein Folding - drug effects | Mass Spectrometry | Mycobacterium tuberculosis - chemistry | Membrane Proteins - metabolism | Ion Channels - chemistry | Phosphatidylglycerols - metabolism | Apoproteins - metabolism | Ammonia - metabolism | Models, Molecular | Aquaporins - metabolism | Escherichia coli Proteins - metabolism | Cardiolipins - metabolism | Escherichia coli - chemistry | Cardiolipins - chemistry | Phosphatidylglycerols - chemistry | Ion Channels - metabolism | Membrane Proteins - chemistry | Protein Stability - drug effects | Membrane Lipids - metabolism | Phosphatidylglycerols - pharmacology | Bacterial Proteins - metabolism | Membrane Lipids - pharmacology | Lipid Bilayers - chemistry | Cation Transport Proteins - chemistry | Escherichia coli Proteins - chemistry | Biological research | Physiological aspects | Lipids | Cooperative binding (Biochemistry) | Research | Structure | Molecular biology | Membrane proteins | Biology, Experimental | Proteins | Studies | Membranes | E coli | Binding sites | Crystal structure
Journal Article
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 03/2011, Volume 286, Issue 10, pp. 7841 - 7853
Mycoplasma pneumoniae is a human pathogen causing respiratory infections that are also associated with serious exacerbations of chronic lung diseases.... 
NUCLEAR-ENVELOPE | CELLS | TRANSLOCATION | CYTOSOLIC PHOSPHOLIPASE A | ACTIVATION | PROTEIN | INNATE IMMUNE-RESPONSES | INFLAMMATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | KINASE | ASTHMA | Tumor Necrosis Factor-alpha - metabolism | Cysteine - analogs & derivatives | Lipopeptides - pharmacology | Humans | Mitogen-Activated Protein Kinase Kinases - immunology | Pulmonary Surfactants - metabolism | Mycoplasma pneumoniae - immunology | Pulmonary Surfactants - immunology | Mitogen-Activated Protein Kinase Kinases - metabolism | Group IV Phospholipases A2 - metabolism | Cysteine - pharmacology | Lipoproteins - metabolism | Toll-Like Receptors - antagonists & inhibitors | Tumor Necrosis Factor-alpha - immunology | Bacterial Proteins - immunology | Cysteine - metabolism | Toll-Like Receptors - metabolism | Cyclooxygenase 2 - immunology | Eicosanoids - immunology | Phosphatidylglycerols - metabolism | Macrophages, Alveolar - immunology | Pneumonia, Mycoplasma - metabolism | Cell Line | Group IV Phospholipases A2 - immunology | Pneumonia, Mycoplasma - immunology | Mycoplasma pneumoniae - metabolism | Phosphatidylglycerols - immunology | Toll-Like Receptors - immunology | Pulmonary Surfactants - pharmacology | Bacterial Proteins - pharmacology | Animals | Lipoproteins - pharmacology | Eicosanoids - metabolism | Cyclooxygenase 2 - metabolism | Phosphatidylglycerols - pharmacology | Bacterial Proteins - metabolism | Mice | Macrophages, Alveolar - metabolism | Lipoproteins - immunology | Cysteine - immunology | Toll-like Receptors (TLR) | MAP Kinases (MAPKs) | Prostaglandins | Lipids | Inflammation | Thromboxane | Cyclooxygenase (COX) Pathway
Journal Article
Journal Article
Journal Article
Journal Article
Pediatric Research, ISSN 0031-3998, 10/2012, Volume 72, Issue 4, pp. 375 - 383
Journal Article
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2012, Volume 35, Issue 9, pp. 1432 - 1439
Indoloquinoline alkaloids represent an important class of antimalarial, antibacterial and antiviral compounds. Indolo[2,3-b]quinolines are a family of DNA... 
erythrocyte ghost | indoloquinoline | partition coefficient | acetylcholinesterase activity | neocryptolepine | hemolysis | Hemolysis | Indoloquinoline | Acetylcholinesterase activity | Partition coefficient | Erythrocyte ghost | Neocryptolepine | ANTIPLASMODIAL ACTIVITY | INDUCED HEMOLYSIS | DRUG DISCOVERY | IN-VITRO | MODEL MEMBRANES | ANTICANCER PRODRUG CPT-11 | CRYPTOLEPIS-SANGUINOLENTA ALKALOIDS | ANTIMALARIAL ACTIVITY | PHARMACOLOGY & PHARMACY | ERYTHROCYTE-MEMBRANE | TOPOISOMERASE-II INHIBITORS | Hemolysis - drug effects | Plant Extracts - chemistry | Plant Extracts - pharmacology | Structure-Activity Relationship | Quinolines - pharmacology | Dose-Response Relationship, Drug | Topoisomerase II Inhibitors - chemistry | Medicine, African Traditional | Cell Membrane - metabolism | Cell Membrane - drug effects | Alkaloids - pharmacology | Quinolines - chemistry | Antineoplastic Agents, Phytogenic - chemistry | Intercalating Agents - pharmacology | Topoisomerase II Inhibitors - pharmacology | Cryptolepis - chemistry | Intercalating Agents - chemistry | Erythrocytes - drug effects | Phosphatidylglycerols - chemistry | Animals | Erythrocytes - metabolism | Hydrophobic and Hydrophilic Interactions | Sheep | Liposomes | Antineoplastic Agents, Phytogenic - pharmacology | Acetylcholinesterase - metabolism | Alkaloids - chemistry | Dimyristoylphosphatidylcholine - chemistry
Journal Article